help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palacio, A.
Right arrow Articles by Schlesinger, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palacio, A.
Right arrow Articles by Schlesinger, L.
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 7 3040-3046
Copyright © 2002 by The Endocrine Society


Special Features

Leptin Levels Are Associated with Immune Response in Malnourished Infants

Ana Palacio, Marcelo Lopez, Francisco Perez-Bravo, Fernando Monkeberg and Liana Schlesinger

Institute of Nutrition and Food Technology, University of Chile, and University Iberoamericana, Santiago, Chile

Address all correspondence and requests for reprints to: Dr. Liana Schlesinger, Institute of Nutrition and Food Technology, Casilla, 138-11 Santiago, Chile. E-mail: . lschlesi{at}uec.inta.uchile.cl

Abstract

Circulating leptin levels, proinflammatory and T helper cells type 1 (Th1), Th2 cytokine production, and lymphoproliferative response were measured in 15 infants with primary moderate protein calorie malnutrition on admission and after recovery of 10% of weight. Sixteen healthy, well nourished infants of comparable age served as controls. A significant deficit in the z-score of weight for age, weight for height, body mass index, and circulating leptin and growth factors were detected in malnourished infants on admission compared with controls (P < 0.05). These deficits were associated with a significant suppression of the lymphoproliferative response, Th1, and proinflammatory cytokine production (P < 0.05). After a 10% weight gain, a significant increase in circulating leptin levels was produced in parallel with a significant increase in Th1 activity, as revealed by an enhancement in interferon-{gamma} and a suppression in IL-4 production. Concomitantly, the lymphoproliferative response became similar to that detected in control infants. Furthermore, a significant increase in IL-1 and TNF{alpha} production compared with that at admission was shown. These findings suggest an association between the increase in leptin and the immunological recovery observed following refeeding of malnourished infants.

ACUTE NUTRITIONAL deprivation affects immune function; in addition, it rapidly reduces circulating leptin in mice and humans (1, 2, 3). Furthermore, impaired cell-mediated immunity has been described in ob/ob and db/db mice, which are known to be defective in leptin or its receptor, respectively (4, 5, 6). Lord et al. (6) reported that the in vitro addition of leptin to mixed lymphocyte cultures increases the proliferative response of T lymphocytes and regulates the T helper type 1 (Th1)/Th2 balance. Moreover, Howard et al. (7) in a recent publication demonstrated that the regimen of recombinant leptin administration during acute starvation was able to completely reverse the effect of starvation on thymic involution and protected against the starvation-induced changes in both thymocyte number and subpopulations proportions. Also, these researchers showed that peripheral administration of recombinant leptin to ob/ob mice reduced thymocyte apoptosis and substantially increased both thymic cellularity and the CD4+ CD8+/CD4- CD8- ratio (7).

Recently, decreased levels of leptin have been demonstrated in severe malnourished infants by Soliman and co-workers (8); however, no link between this decrease and in vivo immune responses has been established to date, despite the fact that a great body of evidence indicates that chronic nutritional deprivation suppresses cellular immune function (9, 10, 11, 12, 13).

The purpose of this study was to investigate whether the decrease in leptin levels is associated with alterations of cell-mediated immunity and with proinflammatory and Th1/Th2 balance in human protein calorie malnutrition (PCM) of moderate severity. Furthermore, to confirm these findings, cell-mediated immunity, proinflammatory cytokines, and the Th1 and Th2 profile were also determined when a significant increase in the circulating leptin level was observed in malnourished infants.

Subjects and Methods

Subjects

In 15 infants with primary moderately intense PCM (seven males and eight females) leptin, growth factor levels, proinflammatory, Th1 and Th2 cytokine production, and lymphoproliferative responses were determined on admission to a Close Nutritional Recovery Center of the Chilean Nutrition Foundation, and after a 10% weight gain. All infants had a birth weight over 2500 g and were free from infections at the time of study (C-reactive protein, <10 mg/liter). Sixteen healthy, well nourished infants (seven males and nine females) of comparable age served as the control group. Informed consent was obtained from the mothers after the aims of the project had been fully explained to them. This study was approved by the ethics in human research committee of the Institute of Nutrition and Food Technology, University of Chile (Santiago, Chile).

Nutritional status

Anthropometric measurements, weight, length, body mass index (BMI) (kilograms per square meter), and skinfold thickness were determined by a registered nurse on admission and after a 10% weight gain. Nude weight was obtained before the first morning feeding with an infant scale (Detecto, Brooklyn, NY) with a precision of 5 g. Body length to the nearest 0.1 cm was determined in the recumbent position using a portable infantometer. The means of three measurements for weight and length were evaluated comparing them to the National Center for Health Statistics standard. Weight for age (W/A) and weight for height (W/H) z scores were calculated with the PCTL9Z anthropometric subroutine (Center for Health Promotion and Education, National Center for Disease Control and Prevention, Atlanta, GA). The percentage of body fat was calculated by skinfold measurements using a Lange caliper (Cambridge, MD, and Washington DC) (14).

Endocrinological measurements

A venous blood sample was obtained after an overnight, 6-h fast, and serum was separated and kept frozen at -20 C until analysis of leptin and growth factors was performed. Serum leptin was measured by RIA (Linco Research, Inc., St. Charles, MO) as previously described and validated (15). The intra- and interassay coefficients of variation were 3.4 and 3.6 ng/ml, respectively.

IGF-I and IGF-binding protein-3 (IGFBP-3) were determined by ELISA. The IGF-I intra- and interassay coefficients of variation were 4.5% and 7% respectively. The IGFBP-3 intra- and interassay coefficients of variation were 4.2% and 6.8%.

Cytokine measurements

Induction of IL-1 TNF{alpha} and IL-6. Peripheral blood mononuclear cells (PBMC) were isolated by Hypaque gradient (Sigma, St. Louis, MO) and washed twice in PBS, and 2.5 x 106 cells/ml were resuspended in RPMI 1640 culture medium supplemented with gentamicin, glutamine, 0.5% heat-inactivated AB plasma, and 1 µg/ml indomethacin. Two hundred microliters of cell suspension were dispensed in 96-well flat-bottom microtiter plates in the absence (spontaneous cytokine release) or the presence of endotoxin [lipopolysaccharide (LPS), 1 µg/ml]. Cultures were incubated for 18 h at 37 C in 5% CO2 and 95% air. Supernatants were collected and kept at -70 C until assays for released cytokines were performed.

Induction of Th1 and Th2 cytokines. The same methodology for cell isolation and culture conditions was applied for induction of these types of cytokines; their production per well was stimulated with 5 µg PHA, 5 ng phorbol acetate myristate, and 0.2 µg ionomycin, and the incubation period was 48 h.

Cytokine determinations

All cytokine determinations were performed using specific, commercial, ELISAs (R\|[amp ]\|D Systems, Inc., Minneapolis, MN). The assay sensitivity was 3.6 pg/ml.

Lymphoproliferative assay

Isolated PBMC were cultured in the presence of PHA and concanavalin A (Con A) for 3 and 5 d, respectively. Unstimulated cells served as controls. Eighteen hours before harvesting, the cells were incubated with 18.5 GBq tritiated thymidine (specific activity, 247.9 GBq/mol) and harvested in an automatic cell harvester (16). Results were expressed as counts per minute.

Statistical analysis

Parametric results were analyzed using Student’s paired and unpaired tests. Nonparametric data were logarithmically transformed to yield normal distributions before parametric analyses were performed. P value less than 0.05 was accepted as statistically significant.

Results

Anthropometric determinations

Table 1Go shows a significant deficit in W/A, W/H, BMI, and percentage of sc fat in the malnourished infants on admission compared with well nourished controls (P < 0.05). A significant increase in the W/A z-score and BMI was induced after 30 d of refeeding, the time interval necessary for 10% weight gain.


View this table:
[in this window]
[in a new window]
 
Table 1. Anthropometric characteristics of PCM infants

 
Endocrinological determinations

Serum leptin levels and IGF-I were significantly lower in the PCM children on admission (Fig. 1Go). After a 10% weight gain, PCM infants experienced significant increases in serum leptin and IGF-I levels, reaching the values observed in the control group. IGFBP-3 had a similar behavior, with mean ± SD values on admission and after 10% weight gain of 2703 ± 333.3 and 2959 ± 343.6 ng/ml (P < 0.05, respectively; mean ± SD of control group, 3213 ± 146.7 ng/ml; P < 0.05 vs. PCM admission values).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Leptin and IGF-I levels in PCM infants. Results are expressed as the mean ± SEM. a, P < 0.05 vs. control; b, P < 0.05 vs. PCM after 10% weight gain.

 
No correlation between log leptin levels and body fat percentage was found in PCM infants on admission; however, after the 10% weight gain, this correlation became as significant as in the control group (Fig. 2Go). A similar situation was observed when the correlation between leptin and IGF-I levels was evaluated in PCM infants (Fig. 3Go); a significant correlation became apparent after 10% weight recovery in PCM children (Fig. 3Go).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 2. Correlation between log leptin and body fat percentage. A, PCM infants on admission; B, PCM infants after 10% weight gain; C, control infants; D, all three groups.

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Correlation between leptin and IGF-I levels. A, PCM infants on admission; B, PCM infants after 10% weight gain; C, control infants.

 
Proinflammatory cytokine production by PBMC

TNF{alpha} production by LPS-stimulated PBMC of malnourished infants was similar to that in the control group on admission, increasing significantly after the 10% weight gain and reaching higher levels than in controls (P < 0.05, by t test; Fig. 4Go). IL-1 production by LPS stimulated PBMC from PCM infants tended to be low on admission compared with that in well nourished controls (0.05 > P < 0.1, by t test; Fig. 4Go). When 10% weight had been achieved, IL-1 production was comparable to that in the control group, with a tendency to become significant compared with the production on admission (0.05 > P < 0.1, calculated by paired t test). Malnourished infants released comparable quantities of IL-6 as well nourished controls on admission and after the 10% weight gain. No differences in spontaneous production of IL-1, TNF{alpha}, and IL-6 from PBMC were detected between the groups in any period of time.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 4. Proinflamatory cytokine production by stimulated PBMC of 15 PCM and 16 control infants. *, Mean ± 1 SD. c, P < 0.05 vs. control; d, P < 0.05 vs. PCM on admission; e, 0.05 > P < 0.1 vs. control; f, 0.05 > P < 0.1 vs. PCM after 10% weight gain.

 
Th1 and Th2 cytokine production by PBMC

Interferon-{gamma} (IFN{gamma}) production by mitogen-stimulated PBMC from PCM infants was similar to that in the control group on admission. However, a significant increase (P < 0.05, by t test and paired t test) was observed after the 10% weight gain compared with well nourished infants and with PCM on admission, respectively (Fig. 5Go). On the other hand, a significantly higher production of IL-4 was detected in PCM subjects compared with well nourished controls on admission (P < 0.05, by t test). After recovery of 10% of initial weight, a significant decrease in the production of this cytokine was shown (P < 0.05, by paired t test). No differences in spontaneous production of IFN{gamma} and IL-4 by PBMC were detected between the groups in any time period.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 5. Th1 and Th2 cytokine production by stimulated PBMC of 7 PCM and 12 control infants. *, Mean ± 1 SD. c, P < 0.05 vs. control; d, P < 0.05 vs. PCM on admission; a, P < 0.05 vs. control; b, P < 0.05 vs. PCM after 10% weight gain.

 
Lymphoproliferative response to mitogens

Malnourished infants showed a significant decrease in the lymphoproliferative response to PHA and Con A on admission compared with controls (P < 0.05). After gaining 10% of initial weight, this response increased to the levels observed in the well nourished group (Table 2Go).


View this table:
[in this window]
[in a new window]
 
Table 2. Lymphoproliferative response to mitogens in PCM infants

 
Discussion

A significant reduction in leptin levels and a trend toward a decrease in proinflammatory and Th1 cytokine production was observed in PCM infants on admission. However, when the infants recovered 10% of their initial weight, circulating hormone levels became normal, associated with a significant increase in cytokine production.

It is well known that circulating leptin concentrations closely correlate with body fat mass and that higher levels of this hormone are observed in obese subjects (15, 17); a decline of leptin levels occurs during acute starvation and weight loss, with return to normal values after refeeding (18). In addition, leptin levels are low in many forms of malnutrition, including intrauterine growth retardation and untreated anorexia nervosa (19, 20). To date few data on leptin levels in protein calorie malnutrition have been reported. Our data show that PCM infants had low leptin serum levels; these results are in agreement with the data recently published by Soliman et al. (8). Interestingly, the recovery of only 10% of weight in our children, which took place approximately 30 d after refeeding, produced a significant increase in the levels of this hormone. The rise in leptin did not parallel the increase in body fat mass, a situation that was also observed in individuals subjected to acute fasting or energy restriction, in which the reduction of leptin levels was not concomitant to the diminution of fat body mass (19). These observations suggest that the leptin concentration is regulated by factors other than fat mass (21). Some researchers postulate that leptin behaves like a signal for energy stores, speculating that the rise of this hormone could represent an adaptive phenomenon necessary for growth development (19). Experimental evidence shows that low leptin levels could be a predictor of body weight gain based on the data of Jacquet et al. (19), who demonstrated that children born with intrauterine growth retardation had higher leptin levels at 1 yr of age compared with normal controls. These researchers (19) suggested that the higher leptin levels in their children could represent an adaptive response that stimulated catch-up growth. An alternative explanation could be that high serum leptin concentrations could reflect a defect in adipose tissue function that impairs the sensitivity of the regulatory system of leptin synthesis and secretion (19). The increasing risk of obesity during adult life of children born with intrauterine growth retardation supports this hypothesis (22).

Recent evidence indicates that cytokines play an important role in the nutrition-infection complex (23). On one hand, an impairment of cytokine production has been reported in malnutrition, and furthermore, infections induce cytokine release, which is known to interfere with metabolic activity and cause appetite loss that alter nutritional status (13, 23, 24). We observed a trend toward reduced PBMC IL-1 production in PCM infants on admission, which agrees with the data reported in malnourished children and anorexia nervosa (12, 25, 26), and explains why these children have an impaired capacity to mount a febrile reaction as a response to infectious agents. TNF{alpha} production by PBMC from PCM infants on admission did not differ from that in normal controls, a finding in disagreement with the results reported by Keenan et al. (25) in adults with anorexia nervosa. On the other hand, IL-6 production in malnourished infants was similar to that in normal controls, results that differ from those of Doherty et al. (27), who reported a diminished production of this cytokine in severe PCM infants, a fact that could explain the difference in our cases with moderate PCM. Surprisingly, when 10% of weight had been gained, a significant increase in IL-1 and TNF{alpha} production, concomitant with the increase in circulating leptin levels, was observed in the PCM patients. Furthermore, Faggione et al. (28) reported that the decrease in leptin levels during fasting contributes to the increased susceptibility to LPS toxicity. These researchers showed that LPS induced a 5-fold greater increase in serum TNF{alpha} in fasted mice compared with fed animals (28). The TNF{alpha} increase was blunted by exogenous leptin replacement, suggesting that leptin could be protective by both inhibiting TNF{alpha} induction by LPS and by reducing TNF{alpha} toxicity. These researchers concluded that leptin exerts a regulatory role on the immune response during the nutritional recovery period (28).

No information correlating leptin levels and cytokine production in human malnutrition is available at present in the current literature. The studies published evaluating the effect of leptin on immune function have been performed only in experimental animals and in in vitro experiments (6, 29). It has been reported that leptin-deficient ob/ob mice cannot clear and kill circulating Escherichia coli as efficiently as normal mice, suggesting that these genetically obese mice have an impaired immune system (29). The possibility that leptin-dependent signals regulate immune function is also supported by the observation that Zucker fa/fa rats, an obese and diabetic strain with deficient leptin receptors, produced suboptimal quantities of proinflammatory cytokines when challenged with LPS (29). Furthermore, studies of macrophages from ob/ob mice (which lack leptin) and db/db mice (which have dysfunctional leptin receptors) show an impaired ability to phagocytize and kill Candida (29, 30). Recombinant leptin restored the phagocytic function of cells from ob/ob mice, but not that of cells from db/db mice, indicating that leptin may regulate macrophage phagocytosis via mechanisms that require direct interactions with its receptor (29). The evidence that leptin can also increase phagocytic activity in macrophages isolated from lean, nondiabetic mice supports these findings and suggests that the phagocytic defect in ob/ob and db/db mice is a direct result of leptin deficiency rather than secondary to obesity-related diabetes (31). These researchers also have demonstrated that leptin is necessary for animals to mount an optimal cytokine response when challenged with endotoxin, a fact supporting our findings and suggesting that this hormone could stimulate proinflammatory cytokine production indirectly by a posttransductional mechanism (29).

Impaired cell-mediated immunity, demonstrated in our study by the decrease in the mitogen-stimulated lymphoproliferative response, is a feature of malnutrition that predisposes to infectious episodes; however, the mechanisms responsible for this alteration remain unknown. When the PCM infants recovered 10% of their weight, leptin levels and lymphoproliferative responses returned to normal, becoming similar to those of well nourished healthy controls. These results are consistent with the findings of Lord et al. (6), who demonstrated that the in vitro addition of leptin to mixed lymphocyte cultures enhanced their proliferative response, the increment being much higher when isolated CD4 cells were employed as responders, suggesting that T lymphocytes are the principal target for leptin action.

Until now, no information on Th1 and Th2 activity has been reported in malnutrition. Our study reveals an imbalance between lymphocyte subpopulations in PCM, demonstrated by the trend toward a decrease in IFN{gamma}, and the increase in IL-4 production, concomitant with the presence of low leptin levels. When a 10% recovery of weight was achieved, a significant enhancement of IFN{gamma} production associated with suppression of IL-4 was shown in parallel with the increase in circulating leptin levels. These findings are similar to those reported by Lord et al. (6), who observed that in vitro leptin addition to PBMC stimulated IL-2 and IFN{gamma} production, indicating that leptin may favor a Th1 response, whereas its absence may promote Th2 activity.

It is possible to speculate that leptin could exert immunological modulation by acting directly on T cell receptors or indirectly, through the hypothalamic-pituitary-adrenal axis. Some time ago we demonstrated that central noradrenergic hyperactivity in malnourished rats could be one of the mechanisms responsible for immunosuppression in malnutrition (32). Leptin may also modulate central noradrenergic activity, and therefore, through this pathway it may regulate immune function (33).

A significant decrease in IGF-I and IGFBP-3 levels was observed in PCM infants on admission, in agreement with previous results (34). With the recovery of 10% of weight, these growth factors increased to levels similar to those in well nourished controls.

Many studies have shown that in rats central leptin infusion stimulates basal secretion of GH, indicating that leptin could act as a neuromodulator of the growth axis (35). We did not measure GH levels in our patients, but we assume that this may be increased. We also postulate that the increased leptin levels could induce an increase in GH sensitivity that contributes to stimulate IGF-I production.

Thus, leptin could play an important role in growth factor regulation as well as in modulation of the immune response. However, immunoregulation may not be attributed only to leptin, because growth factors function as immunomodulators (36, 37). It has been reported that hypophysectomy induces an immunodeficiency in rats that is reversed by administration of GH and PRL (37). Furthermore, GH and IGF-I receptors have been described on the surface of lymphocytes (37). However, in patients with Laron syndrome, a genetic disease characterized by low levels of IGF-I and IGFBP-3, similar to those observed in PCM, no immunological deficits have been reported (37). It is therefore possible that growth factors do not play a fundamental role in immune regulation in PCM.

In conclusion, our findings suggest an association between the increase in leptin and the immunological recovery observed after refeeding of malnourished infants. However, a therapeutic trial is needed as a proof that leptin could enhance Th1 activity in malnutrition.

Acknowledgments

We thank Dr. Oscar Brunser, M.D., and Dr. Illani Atwater, Ph.D., for critical reading of the manuscript.

Footnotes

This work was supported by a grant from University Iberoamericana, Santiago, Chile.

Abbreviations: BMI, Body mass index; Con A, concanavalin A; IFN{gamma}, interferon-{gamma}; IGFBP, IGF-binding protein; LPS, lipopolysaccharide; PBMC, peripheral blood mononuclear cells; PCM, protein calorie malnutrition; Th1 and Th2, T helper cells type 1 and type 2; W/A, weight for age; W/H, weight for height.

Received July 20, 2001.

Accepted March 19, 2002.

References

  1. Holm G, Palmblad J 1976 Acute energy deprivation in man: effect on cell-mediated immnunological reactions. Clin Exp Immunol 25:207–211[Medline]
  2. Boden G, Chen X, Mozzoli M, Ryan I 1996 Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419–3423[Abstract]
  3. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382:250–252[CrossRef][Medline]
  4. Chandra RK, Au B 1980 Spleen hemolytic plaque-forming cell rsponse and generation of cytotoxic cells in genetically obese (C57BL/6J ob/ob) mice. Int Arch Allergy Appl Immunol 62:94–98[Medline]
  5. Fernandes G, Handwerger BS, Yunis EJ, Brown DM 1978 Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest 61:243–250
  6. Lord G, Matarese G, Howard J, Baker R, Bloom S, Lechler R 1998 Leptin modulates the T cell inmune response and reverses starvation-induced immunosuppression. Nature 394:897–900[CrossRef][Medline]
  7. Howard JK, Lord GM, Matarese G, Vendetti S, Ghatei MA, Ritter MA, Lechler RI, and Bloom SR 1999 Leptin protects mice from starvation-induced lymphois atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 104:1051–1059[Medline]
  8. Soliman AT, Elzalabany M, Salama M, Ansari B 2000 Serum leptin concentrations during severe protein energy malnutrition: correlation with growth parameters and endocrine function. Metabolism 49:819–825[CrossRef][Medline]
  9. Schlesinger L, Stekel A 1974 Impaired cellular immunity in marasmic infants. Am J Clin Nutr 27:615–620[Abstract]
  10. Muñoz C, Heresi G, Arévalo M, Saitúa MT, Schlesinger L 1983 Impaired lymphoproliferative response to alloantigens and phytohemagglutinin in marasmic infants. Nutr Res 3:181–183
  11. Schlesinger L, Arevalo M, Arredondo S, Díaz M, Lönnerdal B, Stekel A 1992 Effect of a zinc-fortified formula on immunocompetence and growth of malnourished infants. Am J Clin Nutr 56:491–498[Abstract/Free Full Text]
  12. Muñoz C, Arévalo M, López M, Schlesinger L 1994 Impaired interleukin-1 and tumor necrosis factor production in protein-calorie malnutrition. Nutr Res 14:347–352
  13. Muñoz C, Schlesinger L, Cavaillon J 1995 Interaction between cytokines, nutrition and infection. Nutr Res 15:1815–1844[CrossRef]
  14. Slaughter MH, Lohman TG, Boileau RA, Horswill CA, Stillman RJ, Van Loan MD, Bemben DA 1988 Skinfold equations for estimation of body fatness in children and youth. Hum Biol 60:709–723[Medline]
  15. Considine RV, Shinja MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TI 1996 Serum immunoreactive leptin concentration in normal weight and obese humans. N Engl J Med 334:292–295[Abstract/Free Full Text]
  16. Openheim JJ, Rosentreich DL 1976 Lymphocyte transformation: Utilization of automatic cell harvesters. In: Bloom BR, David JR, eds. In vitro methods in cell-mediated tumor immunity. New York: Academic Press; 73–85
  17. Lonnqvist F, Arner P, Nordfors L, Schalling M 1995 Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nat Med 1:950–953[CrossRef][Medline]
  18. Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF 1996 Response of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45:1511–1515[Abstract]
  19. Jaquet D, Leger J, Tabone M, Czernichow P, Levy-Marchal C 1999 High serum leptin concentrations during catch-up growth of children born with intrauterine growth retardation. J Clin Endocrinol Metab 84:1949–1953[Abstract/Free Full Text]
  20. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, Ma Z, Vignati L, Bowsher R, Herzog D, Klibanski A 1996 Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81:3861–3863[Abstract/Free Full Text]
  21. Soliman AT, Hassan AEH, Aref KM, Hintz RL, Rosenfeld RG, Rogol AD 1986 Serum insulin-like growth factor I and II concentration and growth hormone and insulin responses to arginine infusion in children with protein energy malnutrition before and after nutritional rehabilitation. Pediatr Res 20:1122–1129[Medline]
  22. Ravelli GP, Stein ZA, Susser MW 1976 Obesity in young men after famine exposure in utero and early infancy. N Engl J Med 295:349–353[Abstract]
  23. Grimble RF 1990 Nutrition and cytokine action. Nutr Res Rev 3:193–210
  24. Schlesinger L, Ohlbaum A, Grez L, Stekel A 1976 Decreased interferon production by leukocytes in marasmus. Am J Clin Nutr 29:758–761[Abstract/Free Full Text]
  25. Keenan RA, Moldawer LL, Yang RD, Kawamura I, Blackburn GL, Bistrian BR 1982 An altered response by peripheral leukocytes to synthesize or release leukocyte endogenous mediator in critically ill, protein-malnourished patients. J Lab Clin Med 100:844–857[Medline]
  26. Braskaram P, Sivakuman B 1986 Interleukin-1 in malnutrition. Arch Dis Child 61:182–185[Abstract]
  27. Doherty JF, Golden MHN, Remick DG, Griffin GE 1994 Production of interleukin-6 and tumor necrosis factor-{alpha} in vitro es reduced in whole blood of severely malnourished children. Clin Sci 86:347–351[Medline]
  28. Faggioni R, Moser A, Feingold KR, Grunfeld C 2000 Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Physiol 156:1781–1787
  29. Loffreda S, Yang S, Lin H, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM 1998 Leptin regulates proinflammatory immune responses. FASEB J 12:57–65[Abstract/Free Full Text]
  30. Plotkin B, Paulson D, Chelich A, Jurak D, Cole J, Kasimos J, Budick J, Casteel N 1996 Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and lelucocyte function. J Med Microbiol 44:277–283
  31. Gainsford T, Willson T, Metcalf D 1996 Leptin can induce proliferation, differetation, and functional activation of hemopoietic cells. Proc Natl Acad Sci USA 93:14564–14568[Abstract/Free Full Text]
  32. Schlesinger L, Muñoz C, Arévalo M, López M, Simón V, Hernández A 1994 Depressed immune response in malnourished rats correlates with increased thymic noradrenaline level. Int J Neurosc 77:229–236[Medline]
  33. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS 1997 Leptin inhibition of the hypothalamic pituitary-adrenal axis in response to stress. Endocrinology 138:3859–3863[Abstract/Free Full Text]
  34. Muzzo S, Burrows R, Winterer J, Young I, Malozowski Gelato M, Cassorla F, Merriam G 1990 The growth hormone response to growth hormone releasing hormone stimulation in infantile protein calorie malnutrition. Nutr Res 10:1073–1080[CrossRef]
  35. LaPaglia N, Steiner J, Kirsteins L, Emanuele M, Emanuele N 1998 Leptin alters the response of the growth hormone releasing factor-growth hormone-insulin-like growth factor-I axis to fasting. J Endocrinol 159:79–83[Abstract]
  36. Hooghe Peters E, Hooghe R 1998 Introduction: hormones, blood cells and immunity, with special reference to prolactin, growth hormone and insulin like growth factor-I. Cell Mol Life Sci 54:1057–1058[CrossRef][Medline]
  37. Velkeniers B, Dogusan Z, Naessens F, Hooghe R, Hooghe-Peters L 1998 Prolactin, growth hormone and the immune system in humans. Cell Mol Life Sci 54:1102–1108[CrossRef][Medline]



This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
D. Franchimont, S. Roland, T. Gustot, E. Quertinmont, Y. Toubouti, M.-C. Gervy, J. Deviere, and A. Van Gossum
Impact of Infliximab on Serum Leptin Levels in Patients with Crohn's Disease
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3510 - 3516.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Matarese, S. Moschos, and C. S. Mantzoros
Leptin in Immunology
J. Immunol., March 15, 2005; 174(6): 3137 - 3142.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. L. Chan, S. J. Moschos, J. Bullen, K. Heist, X. Li, Y.-B. Kim, B. B. Kahn, and C. S. Mantzoros
Recombinant Methionyl Human Leptin Administration Activates Signal Transducer and Activator of Transcription 3 Signaling in Peripheral Blood Mononuclear Cells in Vivo and Regulates Soluble Tumor Necrosis Factor-{alpha} Receptor Levels in Humans with Relative Leptin Deficiency
J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1625 - 1631.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. I. Moore, G. B. Huffnagle, G.-H. Chen, E. S. White, and P. Mancuso
Leptin Modulates Neutrophil Phagocytosis of Klebsiella pneumoniae
Infect. Immun., July 1, 2003; 71(7): 4182 - 4185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Halle and P. B. Persson
Role of leptin and leptin receptor in inflammation
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R760 - R762.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Grunfeld
Leptin and the Immunosuppression of Malnutrition
J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3038 - 3039.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palacio, A.
Right arrow Articles by Schlesinger, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palacio, A.
Right arrow Articles by Schlesinger, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals